Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Cumpston

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
Evaluation of prolonged magnesium infusion after allogeneic hematopoietic cell transplantKelsea Seago, Joshua A Goodner, Megan Dillaman, et al.
Clinical Hematology International|October 1, 2021
Low-Dose Acyclovir Prophylaxis for <i>Varicella zoster</i> Reactivation in Autologous Hematopoietic Cell Transplantation RecipientsNaomi Fei, Nilay Shah, Aaron Cumpston, et al.
Leukemia Research and Treatment|July 12, 2017
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet FormulationMorgan Belling, Abraham S Kanate, Alexandra Shillingburg, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological MalignanciesAaron Cumpston, Ryan Caddell, Alexandra Shillingburg, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 30, 2024
Analysis of spontaneous cytomegalovirus clearance after low level reactivation using a pre-emptive treatment threshold of 4,000 IU/mL in allogeneic hematopoietic cell transplant recipientsMadison Walling, Kelsea Seago, Megan Dillaman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 3, 2025
Evaluation of Titer-Proven Response Rates of Pediatric Hepatitis B-Combination Vaccines in Adult Hematopoietic Cell Transplant RecipientsCharles M Gallagher, Spencer K Yingling, Aaron Cumpston, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Bone Marrow Transplantation|April 26, 2022
Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilizationSpencer K Yingling, Rebecca M Gonzalez, Megan Dillaman, et al.
European Journal of Haematology|January 22, 2019
Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignanciesZelia Bowman, Naomi Fei, Janice Ahn, et al.
Pharmacotherapy|November 12, 2021
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controlsAaron W Stewart, Alexandra Shillingburg, William Petros, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
Evaluation of prolonged magnesium infusion after allogeneic hematopoietic cell transplantKelsea Seago, Joshua A Goodner, Megan Dillaman, et al.
Clinical Hematology International|October 1, 2021
Low-Dose Acyclovir Prophylaxis for <i>Varicella zoster</i> Reactivation in Autologous Hematopoietic Cell Transplantation RecipientsNaomi Fei, Nilay Shah, Aaron Cumpston, et al.
Leukemia Research and Treatment|July 12, 2017
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet FormulationMorgan Belling, Abraham S Kanate, Alexandra Shillingburg, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological MalignanciesAaron Cumpston, Ryan Caddell, Alexandra Shillingburg, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 30, 2024
Analysis of spontaneous cytomegalovirus clearance after low level reactivation using a pre-emptive treatment threshold of 4,000 IU/mL in allogeneic hematopoietic cell transplant recipientsMadison Walling, Kelsea Seago, Megan Dillaman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 3, 2025
Evaluation of Titer-Proven Response Rates of Pediatric Hepatitis B-Combination Vaccines in Adult Hematopoietic Cell Transplant RecipientsCharles M Gallagher, Spencer K Yingling, Aaron Cumpston, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Bone Marrow Transplantation|April 26, 2022
Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilizationSpencer K Yingling, Rebecca M Gonzalez, Megan Dillaman, et al.
European Journal of Haematology|January 22, 2019
Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignanciesZelia Bowman, Naomi Fei, Janice Ahn, et al.
Pharmacotherapy|November 12, 2021
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controlsAaron W Stewart, Alexandra Shillingburg, William Petros, et al.
Pageof 5